查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611969

乙酰异羟肟酸市场：按配方、分销管道和应用划分 - 2025-2030 年全球预测

Acetohydroxamic Acid Market by Formulation (Liquid, Tablets/Capsules), Distribution Channel (Hospital Pharmacies, Online Pharmacies), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年乙酰氧肟酸市值为5.5449亿美元，预计2024年将达到5.8926亿美元，复合年增长率为6.39%，到2030年将达到8.5562亿美元。

乙酰羟肟酸 (AHA) 是一种主要用于药用的化合物，特别是用于治疗尿素分解菌引起的尿道感染。其抑制尿素酶酶活性的独特能力对于治疗对传统抗生素抗药性的感染疾病至关重要。对 AHA 的需求是由抗生素抗药性细菌感染疾病的流行以及医学和兽医领域对替代治疗方法的需求所推动的。该化合物也被应用于研究酶活性和代谢异常的研究环境。最终用途包括医院、诊所、实验室、製药厂等。市场成长主要是由于对新型抗生素的需求不断增加以及对尿素酶抑制剂研究的兴趣不断增加所推动的。医疗支出不断增长的新兴国家市场拓展潜力巨大。为了利用这些机会，相关人员应专注于简化供应链并与医疗机构合作。然而，市场面临严格的法律规范、与 AHA 相关的潜在副作用以及现有抗生素的竞争等挑战。需要继续研究安全性和有效性概况以消除这些限制。创新研究和开发工作的重点是开发更多可溶性和生物利用度的製剂，将 AHA 的范围扩大到细菌感染疾病之外，并探索与其他药物的协同效应组合。随着医疗保健产业不断发展以对抗抗生素抗药性，AHA 市场的性质是动态的，要求相关人员灵活应对新的科学发现和监管变化。此外，透过投资教育工作来帮助人们了解 AHA 的好处，并进行市场研究来客製化我们的产品，以有效满足特定地区的医疗需求，公司可能会受益。

主要市场统计
基准年[2023] 55449万美元
预计年份 [2024] 5.8926 亿美元
预测年份 [2030] 85562万美元
复合年增长率（%） 6.39%

市场动态：快速发展的乙酰异羟肟酸市场的关键市场洞察

乙酰异羟肟酸市场正在因供需的动态相互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 越来越多使用乙酰氧肟酸治疗尿素循环障碍
    • 采用乙酰异羟肟酸作为长效肥料添加剂
  • 市场限制因素
    • 原料供应有限且替代品供应有限
  • 市场机会
    • 基于乙酰异羟肟酸的药物的快速核准流程
    • 乙酰异羟肟酸生产技术进展
  • 市场挑战
    • 与乙酰异羟肟酸相关的副作用和环境影响

波特五力：引领乙酰氧肟酸市场的策略工具

波特的五力框架是了解乙酰氧肟酸市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对乙酰异羟肟酸市场的外部影响

外部宏观环境因素对乙酰氧肟酸市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解乙酰异羟肟酸市场竞争状况

对乙酰异羟肟酸市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵乙酰异羟肟酸市场供应商的绩效评估

FPNV定位矩阵是评估乙酰氧肟酸市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製乙酰氧肟酸市场的成功之路

乙酰异羟肟酸市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加乙酰氧肟酸在尿素循环障碍治疗的使用
      • 采用乙酰异羟肟酸作为永续肥料添加剂
    • 抑制因素
      • 原料可得性有限且替代品可得性有限
    • 机会
      • 乙酰异羟肟酸药物的快速核准流程
      • 乙酰异羟肟酸生产技术进展
    • 任务
      • 与乙酰异羟肟酸相关的副作用和环境影响
  • 市场区隔分析
    • 剂型：锭剂和胶囊是合适的，因为它们易于运输、储存，并且可以精确控制剂量。
    • 应用：在医疗领域治疗尿道感染采用率较高
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章乙酰异羟肟酸市场（依配方）

  • 液体
  • 锭剂/胶囊

第七章乙酰异羟肟酸市场：按分销管道

  • 医院药房
  • 网路药房

第八章乙酰异羟肟酸市场：依应用分类

  • 产业
  • 药品

第九章 北美和南美乙酰异羟肟酸市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区乙酰异羟肟酸市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲乙酰异羟肟酸市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 默克宣布大规模扩张韩国生物加工业务
  • 战略分析和建议

公司名单

  • BLD Pharmatech Co., Limited
  • Cayman Chemical
  • Hangzhou Dayangchem Co. Ltd.
  • Henan Tianfu Chemical Co., Ltd.
  • Merck KGaA
  • Mission Pharmacal Company
  • Oakwood Chemical
  • Otto Chemie Pvt. Ltd.
  • Santa Cruz Biotechnology
  • Spectrum Chemical Manufacturing Corp.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
Product Code: MRR-CD5A9334DAA6

The Acetohydroxamic Acid Market was valued at USD 554.49 million in 2023, expected to reach USD 589.26 million in 2024, and is projected to grow at a CAGR of 6.39%, to USD 855.62 million by 2030.

Acetohydroxamic acid (AHA) is a chemical compound primarily used as a pharmaceutical agent, especially in the treatment of urinary tract infections caused by urea-splitting bacteria. Its unique capacity to inhibit urease enzyme activity makes it vital for managing infections that are resistant to traditional antibiotics. The necessity for AHA arises from the growing prevalence of antibiotic-resistant bacterial infections and the need for alternative treatment methods in both the medical and veterinary fields. This compound also finds its application in research settings, where it is used to study enzymatic activities and metabolic disorders. The end-use includes hospitals, clinics, research laboratories, and pharmaceutical manufacturing facilities. The market's growth is predominantly driven by the increased demand for novel antibiotics and a heightened focus on research into urease inhibitors. Emerging economies with rising healthcare expenditures present a significant potential for market expansion. To tap into these opportunities, stakeholders should focus on enhancing supply chain efficiency and forging partnerships with healthcare institutions. However, the market faces challenges like stringent regulatory frameworks, potential side effects associated with AHA, and competition from already established antibiotics. Lifting these limitations requires continuous research into safety and efficacy profiles. Innovation and research could be directed towards developing more soluble and bioavailable formulations, widening AHA's applicability beyond bacterial infections, and exploring synergistic combinations with other pharmaceutical agents. As the healthcare sector constantly evolves to combat antibiotic resistance, the nature of the AHA market is dynamic, requiring stakeholders to agilely adapt to new scientific findings and regulatory changes. Furthermore, businesses could benefit by investing in educational initiatives to promote the understanding of AHA's advantages and by conducting market studies to tailor products to meet specific regional healthcare needs effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 554.49 million
Estimated Year [2024] USD 589.26 million
Forecast Year [2030] USD 855.62 million
CAGR (%) 6.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acetohydroxamic Acid Market

The Acetohydroxamic Acid Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of acetohydroxamic acid to treat urea cycle disorders
    • Adoption of acetohydroxamic acid as a long-acting fertilizer additive
  • Market Restraints
    • Limited availability of raw materials and availability of alternatives
  • Market Opportunities
    • Expedited approval processes for acetohydroxamic acid-based drugs
    • Advancements in production technologies for acetohydroxamic acid
  • Market Challenges
    • Side effects and environmental impacts associated with acetohydroxamic acid

Porter's Five Forces: A Strategic Tool for Navigating the Acetohydroxamic Acid Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acetohydroxamic Acid Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acetohydroxamic Acid Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acetohydroxamic Acid Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acetohydroxamic Acid Market

A detailed market share analysis in the Acetohydroxamic Acid Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acetohydroxamic Acid Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acetohydroxamic Acid Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acetohydroxamic Acid Market

A strategic analysis of the Acetohydroxamic Acid Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acetohydroxamic Acid Market, highlighting leading vendors and their innovative profiles. These include BLD Pharmatech Co., Limited, Cayman Chemical, Hangzhou Dayangchem Co. Ltd., Henan Tianfu Chemical Co., Ltd., Merck KGaA, Mission Pharmacal Company, Oakwood Chemical, Otto Chemie Pvt. Ltd., Santa Cruz Biotechnology, Spectrum Chemical Manufacturing Corp., Thermo Fisher Scientific Inc., and Tokyo Chemical Industry Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Acetohydroxamic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Formulation, market is studied across Liquid and Tablets/Capsules.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies and Online Pharmacies.
  • Based on Application, market is studied across Industrial and Medical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of acetohydroxamic acid to treat urea cycle disorders
      • 5.1.1.2. Adoption of acetohydroxamic acid as a long-acting fertilizer additive
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of raw materials and availability of alternatives
    • 5.1.3. Opportunities
      • 5.1.3.1. Expedited approval processes for acetohydroxamic acid-based drugs
      • 5.1.3.2. Advancements in production technologies for acetohydroxamic acid
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects and environmental impacts associated with acetohydroxamic acid
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Suitability of tablets and capsules formulations owing to their easy-to-transport, store, and precise dosage control
    • 5.2.2. Application: High adoption in medical contexts for treatment of urinary tract infections
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acetohydroxamic Acid Market, by Formulation

  • 6.1. Introduction
  • 6.2. Liquid
  • 6.3. Tablets/Capsules

7. Acetohydroxamic Acid Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies

8. Acetohydroxamic Acid Market, by Application

  • 8.1. Introduction
  • 8.2. Industrial
  • 8.3. Medical

9. Americas Acetohydroxamic Acid Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Acetohydroxamic Acid Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Acetohydroxamic Acid Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Merck KGaA Announces Major Bioprocessing Expansion in South Korea
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BLD Pharmatech Co., Limited
  • 2. Cayman Chemical
  • 3. Hangzhou Dayangchem Co. Ltd.
  • 4. Henan Tianfu Chemical Co., Ltd.
  • 5. Merck KGaA
  • 6. Mission Pharmacal Company
  • 7. Oakwood Chemical
  • 8. Otto Chemie Pvt. Ltd.
  • 9. Santa Cruz Biotechnology
  • 10. Spectrum Chemical Manufacturing Corp.
  • 11. Thermo Fisher Scientific Inc.
  • 12. Tokyo Chemical Industry Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ACETOHYDROXAMIC ACID MARKET RESEARCH PROCESS
  • FIGURE 2. ACETOHYDROXAMIC ACID MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ACETOHYDROXAMIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ACETOHYDROXAMIC ACID MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACETOHYDROXAMIC ACID MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACETOHYDROXAMIC ACID MARKET DYNAMICS
  • TABLE 7. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY TABLETS/CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. ACETOHYDROXAMIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. ACETOHYDROXAMIC ACID MARKET, FPNV POSITIONING MATRIX, 2023